Retinal Implant Market: By Type, By Drug Type, & By Region - Forecast 2016-2021

  • ID: 3974059
  • Report
  • 148 pages
  • IndustryARC
1 of 3
Retinal implants, also known as a bionic eye are biomedical microchips designed to provide visual perception to people suffering from degenerative eye diseases such as retinitis pigmentosa and age-related macular degeneration and have lost vision. Globally, development of efficient and advance technology, rise in the awareness among people retinal implant, increasing government initiative across the globe, growing geriatric population and prevalence of degenerative conditions are the prime growth drivers of global peripheral intervention market. In addition, increase in adoption of retinal implant in emerging economies such as China, India and others, will create new opportunities for global peripheral intervention market. However, higher cost of the research and development, risk of biocompatibility and long-term stability of the material used for devising retinal implants, complex nature of implant surgeries, lack of trained professionals, and higher cost of surgeries are the key restraints for global peripheral intervention market.

Geographically North America dominated global peripheral intervention market because of high medical reimbursement facilities, and technological advancement. Asia Pacific is projected to have fastest growth, owing to rapidly increasing aging population, increasing population of patients suffering from age-related macular degeneration (AMD) and retinitis pigmentosa (RP), rise in consumer awareness, favourable government policies, modernization of healthcare infrastructure, and growing medical tourism industry in developing nations such as China, and India in this region. Among all the drug type, mplantable Miniature Telescope (IMT) has the highest market share in global peripheral intervention market.

This report identifies the global peripheral intervention market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global peripheral intervention market.

This report segments global peripheral intervention market on the basis of type, drug type, and regional market as follows:
Retinal Implant Market, By Type: Epiretinal Implants, Subretinal Implants, and Suprachoroidal Implants
The report has focused study on peripheral intervention market by basis of drug type such as: Argus II, Implantable Telescope, and Alpha IMS
This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region
This report identifies all the major companies operating in the peripheral intervention market. Some of the major companies’ profiles in detail are as follows:
Second Sight Medical Products, Inc.

Retina Implant AG
VisionCare Ophthalmic Technologies, Inc
Bionic Eye Technologies, Inc.

Visus Technology, Inc
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
Note: Product cover images may vary from those shown
2 of 3
1. Retinal Implant Market – Market Overview

2. Executive Summary

3. Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis

4. Retinal Implant Market– Market Forces
4.1. Drivers
4.1.1. Development of efficient and advance technology
4.1.2. Growing geriatric population and prevalence of degenerative conditions
4.2. Restraints
4.2.1. Higher cost of research and development
4.3. Opportunities
4.3.1. Emerging economies
4.4. Challenges
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition

5. Retinal Implant Market– Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors

6. Retinal Implant Market, By Type
6.1. Epiretinal Implants
6.2. Subretinal Implants
6.3. Suprachoroidal Implants

7. Retinal Implant Market, By Drug Type
7.1. Argus II
7.2. Implantable Telescope
7.3. Alpha IMS

8. Retinal Implant Market, By Geography
8.1. Europe
8.1.1. Germany
8.1.2. France
8.1.3. Italy
8.1.4. Spain
8.1.5. Russia
8.1.6. U.K.
8.1.7. Rest of Europe
8.2. Asia Pacific
8.2.1. China
8.2.2. India
8.2.3. Japan
8.2.4. South Korea
8.2.5. Rest of Asia-Pacific
8.3. North America
8.3.1. U.S.
8.3.2. Canada
8.3.3. Mexico
8.4. Rest of the World (RoW)
8.4.1. Brazil
8.4.2. Rest of RoW

9. Retinal Implant – Market Entropy
9.1. Expansion
9.2. Technological Developments
9.3. Merger & Acquisitions, and Joint Ventures
9.4. Supply- Contract

10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
10.1. Second Sight Medical Products, Inc.
10.2. Retina Implant AG
10.3. VisionCare Ophthalmic Technologies, Inc
10.4. Bionic Eye Technologies, Inc.
10.5. Visus Technology, Inc
10.6. Bionic Vision Australia
10.7. Abbott Vascular
10.8. Dräger Medical GmbH
10.9. Hamilton Medical AG
10.10. Philips Healthcare
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

11. Appendix
11.1. Abbreviations
11.2. Sources
11.3. Research Methodology
11.4. Bibliography
11.5. Compilation of Expert Insights
11.6. Disclaimer
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown